MARKET

TMBR

TMBR

Timber Pharmaceuticals Inc
AMEX
1.450
+0.010
+0.69%
After Hours: 1.560 +0.11 +7.59% 18:13 05/31 EDT
OPEN
1.409
PREV CLOSE
1.440
HIGH
1.450
LOW
1.390
VOLUME
10.33K
TURNOVER
0
52 WEEK HIGH
20.50
52 WEEK LOW
1.200
MARKET CAP
4.41M
P/E (TTM)
-0.1207
1D
5D
1M
3M
1Y
5Y
Timber Pharmaceuticals Q4 EPS $(1.32) Up From $(2.50) YoY
Benzinga · 05/16 04:37
BRIEF-Timber Pharmaceuticals Provides Business Update And Announces First Quarter 2023 Financial Results
Reuters · 05/15 21:34
Timber Pharmaceuticals GAAP EPS of -$1.32
Seeking Alpha · 05/15 21:02
Timber Pharmaceuticals Inc: Current report
Press release · 05/15 16:39
Timber Pharmaceuticals Inc: Quarterly report
Press release · 05/15 16:10
Revance Therapeutics, Inc. (RVNC) Reports Q1 Loss, Tops Revenue Estimates
NASDAQ · 05/09 22:05
Bears are Losing Control Over Timber Pharmaceuticals, Inc. (TMBR), Here's Why It's a 'Buy' Now
NASDAQ · 04/14 13:55
HC Wainwright & Co. Reiterates Timber Pharmaceuticals (TMBR) Buy Recommendation
NASDAQ · 04/11 21:52
More
About TMBR
Timber Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of treatments for orphan dermatologic diseases. The Company is also focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), including X-linked recessive CI (XLRI) and autosomal recessive CI (ARCI) and other sclerotic skin diseases. Its lead late-stage program is TMB-001. TMB-003 is its earliest stage program. TMB-001 is a topical formulation of isotretinoin using its patented IPEG delivery system, completed its Phase IIb clinical trial for the treatment of moderate to severe subtypes of CI. The earliest stage product in its pipeline is TMB-003, a formulation of Sitaxsentan, which is a selective endothelin-A receptor antagonist. It is in preclinical development as a locally applied formulation for the treatment of sclerotic skin diseases.

Webull offers kinds of Timber Pharmaceuticals Inc stock information, including AMEX:TMBR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TMBR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TMBR stock methods without spending real money on the virtual paper trading platform.